# ZNF256

## Overview
ZNF256 is a gene that encodes the zinc finger protein 256, a member of the Krüppel-associated box (KRAB) domain-containing zinc finger protein family. This protein is involved in transcriptional regulation, functioning primarily as a transcription factor that can bind to DNA and modulate the expression of various genes. Zinc finger proteins, such as ZNF256, are characterized by their zinc finger motifs, which facilitate DNA binding and are crucial for their role in gene regulation. ZNF256 has been implicated in several biological processes and diseases, particularly in the context of cancer, where it is associated with tumor suppression and prognosis. Its expression levels and epigenetic modifications have been studied in various cancer types, including kidney renal clear cell carcinoma and diffuse large B-cell lymphoma, highlighting its potential as a biomarker and therapeutic target (Liu2017Integrated; Czerwinska2021Low; Zhang2023Integrated).

## Function


## Clinical Significance
ZNF256 has been implicated in various cancers due to its role in transcriptional regulation. In kidney renal clear cell carcinoma (KIRC), ZNF256 is part of a group of KRAB-ZNF transcription factors that are associated with better patient survival outcomes when upregulated. These factors, including ZNF256, are thought to act as tumor suppressors, with their higher expression linked to reduced cancer stemness and improved prognosis (Czerwinska2021Low). 

In diffuse large B-cell lymphoma (DLBCL), ZNF256 is identified as one of the genes that are hypermethylated and downregulated in patients with TET2 mutations. This alteration in expression may serve as a potential biomarker for diagnosing DLBCL, highlighting the gene's significance in the context of TET2 mutations and lymphoma pathogenesis (Liu2017Integrated).

ZNF256 has also been noted in the context of cancer immunotherapy. Differential expression analysis across multiple immunotherapy datasets identified ZNF256 as one of the genes with significant expression changes, suggesting its potential role in influencing immunotherapy response (Zhang2023Integrated). These findings underscore the clinical significance of ZNF256 in cancer prognosis and treatment strategies.

## Interactions



## References


[1. (Liu2017Integrated) Pengfei Liu, Wenhua Jiang, Jinkun Zhao, and Huilai Zhang. Integrated analysis of genome-wide gene expression and dna methylation microarray of diffuse large b-cell lymphoma with tet mutations. Molecular Medicine Reports, 16(4):3777–3782, July 2017. URL: http://dx.doi.org/10.3892/mmr.2017.7058, doi:10.3892/mmr.2017.7058. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2017.7058)

[2. (Czerwinska2021Low) Patrycja Czerwinska and Andrzej Adam Mackiewicz. Low levels of trim28-interacting krab-znf genes associate with cancer stemness and predict poor prognosis of kidney renal clear cell carcinoma patients. Cancers, 13(19):4835, September 2021. URL: http://dx.doi.org/10.3390/cancers13194835, doi:10.3390/cancers13194835. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13194835)

[3. (Zhang2023Integrated) A-Yuan Zhang, Rui-Jun Yang, Peng Ge, and Xin Li. Integrated analysis of gene expression profiles reveals prognostic biomarkers for immunotherapy in cancer. Medical Data Mining, 6(4):22, 2023. URL: http://dx.doi.org/10.53388/mdm202306022, doi:10.53388/mdm202306022. This article has 0 citations.](https://doi.org/10.53388/mdm202306022)